Mumps-specific antibody levels before and after vaccination with live mumps vaccines were determined by enzyme-linked immunosorbent assay (ELISA) and neutralization tests. A correlation was found between neutralization titers and optical density in ELISA. However, postvaccination sera from some vaccinees who failed to seroconvert by neutralization contained significant levels of mumps-specific antibody detectable by ELISA. In some of these serum specimens, the antibody directed to the F polypeptide of mumps virus was predominant. Most sera positive in ELISA neutralized mumps virus upon the addition of fresh guinea pig serum to the virus-serum mixture.
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Neutralizing (NT) antibody is currently considered as the most reliable index of the immunity level to mumps virus infection (3, 5) . The immunogenicity of live attenuated mumps vaccines has been evaluated by the ability to induce an NT antibody response. Determination of NT antibody is, however, labor intensive and time consuming. Enzymelinked immunosorbent assay (ELISA), because of its simplicity and rapidity, is gaining increasingly wider acceptance as a serodiagnostic method (9, 13, 18, 20, 21) . It has also been used as a sensitive test for vaccination-induced antibody response (9, 19) . With the purpose of determining whether ELISA could be used as a substitute for the NT test in the evaluation of vaccines, we tested serum samples obtained before and after vaccination with live mumps vaccines. A small proportion of vaccinees failed to show seroconversion when postvaccination sera were tested by NT test but did seroconvert by ELISA. We therefore studied the nature and the possible protective role of the antibody detected by ELISA but not by the NT test.
MATERIALS AND METHODS
Antigens. Mumps virus Enders strain propagated in the allantoic cavity of embryonated chicken eggs was used for ELISA antigen and radiolabeling. For both purposes, virus was purified from infected allantoic fluid by pelleting and two cycles of banding, first through 20% sucrose onto a 50% (wt/wt) sucrose cushion, then through a 20 to 50% linear sucrose gradient at 25,000 rpm for 4 ELISA. Each well of polystyrene flat-bottomed microtiter plates (M-129A; Dynatech, Plochingen, West Germany) was coated overnight at 4°C with 100 ,ul of purified mumps virus, diluted overnight in carbonate-bicarbonate buffer (pH 9.6) to a concentration of 0.5 jig of protein per ml and then washed.
Washing in this and all subsequent steps was done by four times in 150 p.l of phosphate-buffered saline containing 0.05% Tween 20. A total of 100 ,ul of test serum diluted 1:200 was added in duplicate to antigen-coated wells and left for 2 h at room temperature. The diluent for both test sera and the following enzyme-conjugated secondary antibody was phosphate-buffered saline-0.05% Tween 20 containing 0.1% bovine serum albumin. After washing, 100 p.1 of peroxidaseconjugated goat anti-human immunoglobulin G (heavy chain specific; Cappel Laboratories, Cochraville, Pa.) diluted 1:4,000 was added. After incubation for 1 h at room temperature and washing, 100-,ul volumes of freshly prepared substrate (0.4 mg of o-phenylenediamine per ml, 0.012% hydrogen perioxide in citrate-phosphate buffer, pH 5.0) were added. The reaction was allowed to proceed for 30 min at room temperature in the dark before the addition of 25 p.1 of 2 M sulfuric acid. Optical density (OD) was measured by photometer (Titertek Multiskan; Flow Laboratories, Inc., Rockville, Md.) at 492 nm. A battery of positive and negative reference sera were always included. The standard deviation within the same test or between tests was less than 10% of the mean OD value for the positive reference sera. This variability is comparable to that reported earlier (18, 20) .
HI test. HI antibody titers of sera against parainfluenza viruses were determined with 4 hemagglutinating units of antigen and guinea pig erythrocytes. Before the test, nonspecific inhibitors were removed from sera by treatment with a receptor-destroying enzyme of Vibrio cholerae (Takeda Chemical Industries, Osaka, Japan). HI titers were expressed as the reciprocals of the highest initial dilutions of sera which completely inhibited hemagglutination.
Electrophoretic analyses of immunoprecipitates. Radioisotopic labeing of purified mumps virus with [3H]succinimidyl propionate (Radiochemical Centre, Amersham, England) was performed by a method described previously (6) . To 20 p.l of radiolabeled virus (about 400,000 cpm) lysed with 100 p.l of RIPA buffer (0.15 M NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0. NT ( log2) (4, 10, 14, 17) , it was apparent that the method we adopted did not result in uniform labeling of viral was kept at 4°C overnight. The subsequent procedures of immunoprecipitation were described by Lamb et al. (8) . The eluted antigen-antibody complexes were electrophoresed in 10% polyacrylamide gels by the method described by Laemmli (7) . The gels were dried and fluorographed (1). NT tests. NT tests were done in Vero cells. In conventional NT tests, fourfold serial dilutions of sera were mixed with the virus which was diluted to give 20 to 30 PFU per well. The mixture was kept at 35°C for 1 h and inoculated into two wells, each on 24-well (16-mm) Linbro plastic plates. The serum dilution causing 50% plaque reduction was taken as the endpoint. In the complement-mediated NT test, fresh guinea pig serum was added to the virus-serum mixture at a final concentration of 1:400 after the initial incubation period. The final mixture was incubated for an additional 1 h before inoculation.
RESULTS
Correlation between ELISA and NT test. There was a good correlation between ELISA OD values and NT antibody levels in 49 paired serum samples from vaccinees responding to vaccination by an NT antibody rise (Fig. 1) . About 60% of the vaccinees were initially seronegative, and the remainder were already seropositive before vaccination but showed an increase in NT antibody titer after vaccination. All prevaccination sera with NT antibody titers of less than 1:4 fell below the cutoff level in ELISA, except one specimen. The polypeptides. The polypeptides located near the envelope, HN, F, and M, were more heavily labeled than those located internally. The content or accessibility of residues susceptible to chemical modification also appeared to contribute to the different degree of labeling of polypeptides (Fig. 3, lane  10) .
The immunoprecipitates produced by representative serum samples with different reactivity patterns are shown in Fig. 3, lanes 1 to 9 . Viral polypeptides precipitated by postvaccination sera positive in ELISA (lanes I to 6) included HN, NP, F, and M polypeptides. The major difference between sera with (lane 1 to 3) and without (lanes 4 to 6) NT activity was in the amount of HN polypeptide precipitated. Whereas the former serum samples produced distinct bands of HN polypeptide, barely detectable HN bands were shown by the latter serum samples. On the other hand, similar amounts of F polypeptide was precipitated by both groups of sera. The antibody reacting with NP and M polypeptides was not present regularly. In some of the NT-negative postvaccination sera (e.g., Fig. 3 , lane 6 or Table 2 , vaccinee 7), the antibody directed to F polypeptides appeared to be responsible for the positive reaction in ELISA. Although the preferential labeling of F over HN polypeptides in this experiment made it difficult to precisely quantify the relative abundance of antibody to the two polypeptides, the predominance of antibody to F polypeptide in this particular serum was confirmed in the experiment in which [35S]methionine-labeled mumps virus-infected Vero cell extract was used as antigen for immunoprecipitation (data not shown).
Complement-mediated neutralization. The above findings suggest that the antibody directed to F polypeptide bound to the virus but was not as efficient in NT as that which bound to HN polypeptide. It was possible, however, that the activation of the complement pathway leads to the eventual neutralization of a virus-antibody complex. Table 2 shows the results of such an experiment with representative vaccinees. Vaccinees 4 to 9, who responded to vaccination with various strains by antibody rises detectable by ELISA but not by conventional NT tests, were found to have seroconverted in NT tests when fresh guinea pig serum was added to the preincubated virus-serum mixtures. The guinea pig serum alone at the dilution employed did not affect the infectivity of mumps virus. With NT-positive sera, NT titers were further augmented by the addition of guinea pig serum. There were five vaccinees whose postvaccination sera were negative in ELISA. Three of the samples available for testing were also negative in complement-mediated NT tests. Thus, the presence of antibody detected by ELISA was found to be correlated with NT activity demonstrable in the presence of fresh guinea pig serum.
DISCUSSION
Previous studies showed that serum NT antibody levels of 1:2 or higher against a challenge of 30 to 100 virus 50% tissue culture infective doses, or of 1:4 or higher in 50% plaque reduction tests are associated with protection against natural mumps infection during epidemics (3, 5 Fig. 3 , lane 5. e The immunoprecipitation pattern is shown in Fig. 3 , lane 6.
-
The immunoprecipitation pattern is shown in Fig. 3 , lane 3. the presence of antibody directed to HN polypeptide. ELISA-positive, NT-negative postvaccination sera contained less antibody to HN polypeptide than did NT-positive sera but did contain comparable amounts of antibody to F polypeptide. The addition offresh guinea pig serum rendered these sera capable of neutralizing mumps virus. According to Orvell (15) , the absorption of mumps convalescent human serum specimens with Tween 80-ether-treated mumps virus depleted HI antibody, leaving non-HI, hemolysis-inhibiting antibody. Non-HI, hemolysis-inhibiting antibody was less efficient in neutralization than was HI antibody, but the neutralizing activity was markedly enhanced by anti-human immunoglobulin G. In a subsequent study, the same author immunized rabbits with purified glycoproteins of mumps virus and confirmed that the HI and the non-HI, hemolysisinhibiting antibodies represented antibodies directed to HN and F proteins, respectively (16) . The latter antibodies did not neutralize infectivity. Importance of antibody to F polypeptide has been emphasized for the defense against paramyxovirus infection (2). The argument was based on the evidence obtained mainly with SV5, in which antibody to F polypeptide per se had neutralizing activity (11, 12) . In contrast, antibody to the F polypeptide has not been shown to be very effective in direct neutralization of mumps virus (15, 16 
